Despite the Internet being around for quite some time, the FDA has never issued specific guidance to pharmaceutical companies on how they can communicate about and market their products online, instead stating that the existing guidelines for print and television should be applied. However, there is difficulty in interpretation: if providing the prescribing information on the back of a print ad is acceptable, is that equal to having the information one click away? Instead of official guidance and directives, we learn what is okay – and what doesn’t fly – through…
Tag Archives: DDMAC
Health Digital Check-Up: What’s Going on at the FDA
September 7, 2010
Health Digital Check-Up: The FDA Warns About Facebook Share
August 10, 2010
As we wait for the official word from the FDA on how the DDMAC guidelines should be applied to the digital space, we can learn how the FDA is interpreting the use of social media for promotional activities through their warning letters. Novartis Pharmaceuticals Corporation (an Edelman client, though not for this particular promotion) recently received a warning letter…
